157 related articles for article (PubMed ID: 8174418)
1. Tissue-specific alterations of binding sites for peripheral-type benzodiazepine receptor ligand [3H]PK11195 in rats following portacaval anastomosis.
Rao VL; Audet R; Therrien G; Butterworth RF
Dig Dis Sci; 1994 May; 39(5):1055-63. PubMed ID: 8174418
[TBL] [Abstract][Full Text] [Related]
2. Portacaval anastomosis causes selective alterations of peripheral-type benzodiazepine receptor expression in rat brain and peripheral tissues.
Desjardins P; Bandeira P; Rao VL; Butterworth RF
Neurochem Int; 1999 Oct; 35(4):293-9. PubMed ID: 10482349
[TBL] [Abstract][Full Text] [Related]
3. Densities of binding sites for the "peripheral-type" benzodiazepine receptor ligand 3H-PK11195 are increased in brain 24 hours following portacaval anastomosis.
Leong DK; Therrien G; Swain MS; Butterworth RF
Metab Brain Dis; 1994 Sep; 9(3):267-73. PubMed ID: 7838068
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein mRNA in brain following portacaval anastomosis.
Desjardins P; Bandeira P; Raghavendra Rao VL; Ledoux S; Butterworth RF
Brain Res; 1997 May; 758(1-2):255-8. PubMed ID: 9203558
[TBL] [Abstract][Full Text] [Related]
5. Increased densities of binding sites for the 'peripheral-type' benzodiazepine receptor ligand [3H]PK 11195 in rat brain following portacaval anastomosis.
Giguère JF; Hamel E; Butterworth RF
Brain Res; 1992 Jul; 585(1-2):295-8. PubMed ID: 1324770
[TBL] [Abstract][Full Text] [Related]
6. Increased densities of binding sites for the "peripheral-type" benzodiazepine receptor ligand [3H]PK11195 in vulnerable regions of the rat brain in thiamine deficiency encephalopathy.
Leong DK; Le O; Oliva L; Butterworth RF
J Cereb Blood Flow Metab; 1994 Jan; 14(1):100-5. PubMed ID: 8263044
[TBL] [Abstract][Full Text] [Related]
7. Characterization of central- and peripheral-type benzodiazepine receptors in rat salivary glands.
Yamagishi H; Kawaguchi M
Biochem Pharmacol; 1998 Jan; 55(2):209-14. PubMed ID: 9448744
[TBL] [Abstract][Full Text] [Related]
8. In vivo receptor labeling of peripheral benzodiazepine receptor by ex vivo binding of [3H]PK11195.
Funakoshi T; Chaki S; Okuyama S; Okubo T; Nakazato A; Nagamine M; Tomisawa K
Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):35-41. PubMed ID: 10850367
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic chlorpromazine treatment on peripheral benzodiazepine binding sites in heart, kidney, and cerebral cortex of rats.
Gavish M; Weizman R
J Neurochem; 1989 May; 52(5):1553-8. PubMed ID: 2540276
[TBL] [Abstract][Full Text] [Related]
10. Increased densities of binding sites for the peripheral-type benzodiazepine receptor ligand [3H]PK 11195 in congenital ornithine transcarbamylase-deficient sparse fur mouse.
Rao VL; Qureshi IA; Butterworth RF
Pediatr Res; 1993 Dec; 34(6):777-80. PubMed ID: 8108192
[TBL] [Abstract][Full Text] [Related]
11. Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites.
Awad M; Gavish M
J Neurochem; 1987 Nov; 49(5):1407-14. PubMed ID: 2822854
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effects of thyroxine treatment on central and peripheral benzodiazepine receptors in the rat.
Gavish M; Weizman A; Okun F; Youdim MB
J Neurochem; 1986 Oct; 47(4):1106-10. PubMed ID: 3018159
[TBL] [Abstract][Full Text] [Related]
13. Modulation of peripheral benzodiazepine binding sites following chronic estradiol treatment.
Gavish M; Okun F; Weizman A; Youdim MB
Eur J Pharmacol; 1986 Aug; 127(1-2):147-51. PubMed ID: 3019723
[TBL] [Abstract][Full Text] [Related]
14. Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain.
Rao VL; Butterworth RF
Eur J Pharmacol; 1997 Dec; 340(1):89-99. PubMed ID: 9527511
[TBL] [Abstract][Full Text] [Related]
15. Increased "peripheral-type" benzodiazepine receptor sites and mRNA in thalamus of thiamine-deficient rats.
Desjardins P; Todd KG; Hazell AS; Butterworth RF
Neurochem Int; 1999 Nov; 35(5):363-9. PubMed ID: 10517697
[TBL] [Abstract][Full Text] [Related]
16. Regional distribution and kinetics of three sites on the GABAA receptor: lack of effect of portacaval shunting.
Mans AM; Kukulka KM; McAvoy KJ; Rokosz NC
J Cereb Blood Flow Metab; 1992 Mar; 12(2):334-46. PubMed ID: 1312540
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ligand binding to mitochondrial benzodiazepine receptors.
Hirsch JD; Beyer CF; Malkowitz L; Loullis CC; Blume AJ
Mol Pharmacol; 1989 Jan; 35(1):164-72. PubMed ID: 2536464
[TBL] [Abstract][Full Text] [Related]
18. Direct interactions of androgenic/anabolic steroids with the peripheral benzodiazepine receptor in rat brain: implications for the psychological and physiological manifestations of androgenic/anabolic steroid abuse.
Masonis AE; McCarthy MP
J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):551-5. PubMed ID: 8918981
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic haloperidol treatment on peripheral benzodiazepine binding sites in cerebral cortex of rats.
Gavish M; Weizman R; Becker D; Tanne Z
J Neural Transm; 1988; 74(2):109-16. PubMed ID: 2853202
[TBL] [Abstract][Full Text] [Related]
20. Chronic exposure of rat primary astrocyte cultures to manganese results in increased binding sites for the 'peripheral-type' benzodiazepine receptor ligand 3H-PK 11195.
Hazell AS; Desjardins P; Butterworth RF
Neurosci Lett; 1999 Aug; 271(1):5-8. PubMed ID: 10471200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
